Hoch Lynelle - Insider Non-Derivative Transactions at BRISTOL MYERS SQUIBB CO (BMY) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Mar 10, 2024, Hoch Lynelle's relationship to BRISTOL MYERS SQUIBB CO (BMY) is Officer (President, Cell Therapy Org.), and currently has 3,781 shares of Common Stock, $0.10 par value.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BMY insiders.

Data Source: SEC.
Hoch Lynelle - Insider Non-Derivative Transactions of BMY Common Stock, $0.10 par value
Hoch Lynelle - Insider Non-Derivative Transactions at BMY
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Mar 11, 2024 F -- (Common Stock, $0.10 par value) 197 53.79 257
Mar 11, 2024 J -- (Common Stock, $0.10 par value) 85 0 454
Mar 11, 2024 F -- (Common Stock, $0.10 par value) 194 53.79 513
Mar 11, 2024 M -- (Common Stock, $0.10 par value) 539 0 539
Mar 11, 2024 J -- (Common Stock, $0.10 par value) 94 0 707
Mar 11, 2024 M -- (Common Stock, $0.10 par value) 544 0 801
Mar 11, 2024 F -- (Common Stock, $0.10 par value) 917 53.79 1726
Mar 11, 2024 J -- (Common Stock, $0.10 par value) 1138 0 2643
Mar 11, 2024 M -- (Common Stock, $0.10 par value) 3268 0 3781